When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Exclusive-US FDA finds widely used asthma drug impacts ... - AOL

   www.aol.com/news/exclusive-us-fda-finds-widely...

   By 2019, the FDA tallied 82 suicides linked to Singulair and its generic versions reported to its adverse-event database since 1998. At least 31 of those reports involved someone age 19 or younger.

3. Montelukast - Wikipedia

   en.wikipedia.org/wiki/Montelukast

   Montelukast, sold under the brand name Singulair among others, is a medication used in the maintenance treatment of asthma. [6] It is generally less preferred for this use than inhaled corticosteroids . [ 6 ]

4. Mayo Clinic - Wikipedia

   en.wikipedia.org/wiki/Mayo_Clinic

   Mayo Clinic is a nonprofit hospital system with campuses in Rochester, Minnesota; Scottsdale and Phoenix, Arizona; and Jacksonville, Florida. [22] [23] Mayo Clinic employs 76,000 people, including more than 7,300 physicians and clinical residents and over 66,000 allied health staff, as of 2022. [5]

5. Mayo Clinic Proceedings - Wikipedia

   en.wikipedia.org/wiki/Mayo_Clinic_Proceedings

   Mayo Clinic Proceedings is a monthly peer-reviewed medical journal published by Elsevier and sponsored by the Mayo Clinic. It covers the field of general internal medicine. The journal was established in 1926 as the Proceedings of the Staff Meetings of the Mayo Clinic and obtained its current name in 1964. The journal started online publishing ...

6. FDA approves new pain medication as an alternative to opioids ...

   www.aol.com/news/fda-approves-pain-medication...

   For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

7. FDA approves opioid-free pain medication with 'no sign of ...

   www.aol.com/fda-approves-opioid-free-pain...

   A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...